{"gene":"GNAI1","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":2021,"finding":"Pathogenic mutations at Gln52 of GNAI1 (e.g., Gαi1[Gln52Pro]) abolish GTP binding and hydrolysis (the fundamental biochemical activity of Gαi1), cause defective interaction with partner proteins that recognize either GDP-loaded or GTP-loaded forms, and strongly reduce plasma membrane localization of the mutant proteins.","method":"Biochemical GTP binding/hydrolysis assays, co-immunoprecipitation with partner proteins, subcellular localization analysis of mutant vs. wild-type Gαi1 in cell lines","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal biochemical and cell-biological methods in a single study; single lab","pmids":["34685729"],"is_preprint":false},{"year":2025,"finding":"Five GNAI1 syndrome-associated missense variants alter D2 receptor (D2R) signaling in Xenopus oocytes: four variants (T48K, T48I, C224Y, V332E) cause gain-of-function increases in dopamine potency and constitutive G protein activity, while G40C is unresponsive to D2R activation. All variants show reduced GTP-γ-S binding rates and undetectable GTP hydrolysis except T48I, which shows accelerated binding and hydrolysis.","method":"Xenopus laevis oocyte electrophysiology expressing D2R plus variant Gαi1 proteins; GTP-γ-S binding assays; in silico modeling","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted receptor-G protein signaling in oocytes with biochemical GTP assays; multiple variants tested with orthogonal methods in one rigorous study","pmids":["41329793"],"is_preprint":false},{"year":2025,"finding":"GNAI1 is required for ciliogenesis in human ciliated cells. Patient-variant orthologues T48I, K272R, A328P, and V334E disrupt both cilia assembly and function in C. elegans AWC neurons; D173V/K270R/A326P human GNAI1 variants disrupt ciliary localization of Gαi1 in human ciliated cell lines; M88V and I321T variants have no detectable effect on cilia phenotypes.","method":"CRISPR-Cas9 knock-in of patient variants in C. elegans; cilia morphology assays; chemotaxis behavioral assays; human ciliated cell lines with variant Gαi1 expression and ciliary localization imaging","journal":"Genetics","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — CRISPR-edited whole-organism model with multiple orthogonal readouts (morphology, behavior, localization), validated in human cells, published and preprint concordant","pmids":["41052774","40894620"],"is_preprint":false},{"year":2019,"finding":"GNAI1 and GNAI3 interact with proteins in the IL6 signaling pathway (shown by immunoprecipitation) and their combined loss activates the JAK2-TRAF6-TAK1-CHUK/IKKβ axis (NF-κB) and JAK2-STAT3 axis, leading to upregulation of GNAI2, GP130, and iNOS and expansion of MDSCs; conditional Gnai2 deletion in CD11c+ cells of GNAI1/3 double-knockout mice prevents NF-κB and STAT3 activation, placing GNAI2 downstream of GNAI1/3 in this pathway.","method":"Immunoprecipitation of GNAI1/3 with IL6 pathway proteins from colon tumor tissue and MEFs; genetic epistasis using conditional Gnai2 knockout in DKO mice; immunoblot; flow cytometry; ELISA","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP plus genetic epistasis (double and conditional KO) plus multiple orthogonal readouts; replicated across cell types and in vivo","pmids":["30836096"],"is_preprint":false},{"year":2012,"finding":"GNAI1 suppresses migration and invasion of hepatocellular carcinoma cells; knockdown of GNAI1 increases migration/invasion and overexpression reduces it. miR-320a/c/d target GNAI1 at the post-transcriptional level (protein downregulated without mRNA change in HCC), and miR-320 mimics reduce GNAI1 protein and promote cell migration/invasion.","method":"Lentiviral GNAI1 overexpression; siRNA knockdown; Transwell migration/invasion assays; Western blot after miR-320a/c/d mimic transfection; qRT-PCR","journal":"Cancer biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — loss- and gain-of-function with defined phenotypic readout; miRNA-target relationship confirmed by protein-level measurement; single lab","pmids":["23691483"],"is_preprint":false},{"year":2015,"finding":"Valproic acid induces miR-124, which targets GNAI1 mRNA to reduce GNAI1 protein levels, thereby de-repressing adenylate cyclase, increasing cAMP, and elevating BDNF expression; miR-124 mimic or inhibitor can correspondingly manipulate GNAI1 protein and BDNF mRNA levels.","method":"miR-124 mimic/inhibitor transfection; Western blot for GNAI1; qRT-PCR for Bdnf mRNA; in silico miRNA target prediction validated by protein-level changes","journal":"Neurochemistry international","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab; miRNA-target relationship inferred from expression changes without 3'UTR reporter assay; no direct cAMP measurement confirmed","pmids":["26519098"],"is_preprint":false},{"year":2022,"finding":"Puerarin directly binds GNAI1 (identified by DARTS combined with mass spectrometry), and this interaction inhibits GNAI1's suppression of adenylate cyclase, increasing cAMP production and activating PKA/CREB signaling in podocytes; PKA inhibition abrogates puerarin's protective effects on high-glucose-induced apoptosis.","method":"Drug affinity responsive target stability (DARTS) assay plus mass spectrometry for target ID; cAMP measurement in human podocytes and diabetic mouse kidney; CREB phosphorylation by Western blot; Rp-cAMP PKA inhibition rescue experiment","journal":"Journal of cellular and molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding identified by DARTS-MS, functional consequence validated by cAMP measurement and pharmacological epistasis; single lab","pmids":["35678269"],"is_preprint":false},{"year":2023,"finding":"Neuroglobin (NGB) physically interacts with GNAI1 (shown by co-IP) and reduces GNAI1 protein expression; this interaction inhibits downstream EGFR phosphorylation and the AKT/ERK pathway, suppressing pancreatic cancer proliferation and metastasis.","method":"Co-immunoprecipitation; Western blot for GNAI1 and p-EGFR/AKT/ERK; in vitro and in vivo functional assays with NGB overexpression","journal":"Biochemical and biophysical research communications","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP; pathway placement inferred from correlated protein changes without direct epistasis; single lab","pmids":["37141638"],"is_preprint":false},{"year":2024,"finding":"miR-320d in colorectal cancer-derived exosomes is transferred to vascular endothelial cells where it targets GNAI1 3'UTR, reducing GNAI1 protein, which increases JAK2/STAT3 activation and VEGFA production, enhancing endothelial migration and angiogenesis.","method":"Exosome transfer experiments; luciferase reporter assay (implied by 'targeting' GNAI1); Western blot for GNAI1, JAK2/STAT3, VEGFA; endothelial migration and tube formation assays; in vivo tumor models","journal":"Cell death & disease","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab; mechanistic link between GNAI1 reduction and JAK2/STAT3 not directly established with rescue experiment; abstract does not confirm 3'UTR reporter","pmids":["39695099"],"is_preprint":false},{"year":2026,"finding":"Patchouli alcohol (PA) directly binds GNAI1 (confirmed by DARTS, molecular docking, and CETSA), disrupts the GNAI1-ARRB1 (β-arrestin-1) protein complex, and this dissociation inhibits ERK/JAK2-STAT3/mTOR pro-survival signaling, triggering autophagic cell death in non-small cell lung cancer cells.","method":"DARTS, CETSA, and molecular docking for direct target ID; co-immunoprecipitation for GNAI1-ARRB1 interaction; Western blot for downstream pathway proteins; in vitro and in vivo NSCLC models","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — three orthogonal methods for direct binding, plus Co-IP for interaction disruption; single lab","pmids":["42088441"],"is_preprint":false},{"year":2022,"finding":"Transcriptome analysis of Ostm1-null mouse DN1 T cells identified a Foxo1-Klf2-S1pr1-Gnai1-Rac1 signaling axis downstream of Ostm1; Ostm1 ablation disrupts this axis and impairs early T cell development, and transgenic Ostm1 rescue in DN1 cells normalizes the pathway and T cell subpopulations.","method":"Transcriptome analysis of sorted DN1 cells from Ostm1 KO mice; genetic rescue with transgenic Ostm1 expression; flow cytometry for T cell subpopulations","journal":"iScience","confidence":"Low","confidence_rationale":"Tier 3 / Weak — Gnai1 pathway placement is from transcriptome correlation in KO context; no direct manipulation of Gnai1 in this study","pmids":["35434560"],"is_preprint":false}],"current_model":"GNAI1 encodes Gαi1, a heterotrimeric G protein α-subunit that inhibits adenylate cyclase (suppressing cAMP/PKA/CREB signaling), transduces inhibitory GPCR signals (including dopamine D2R), is required for ciliogenesis, physically interacts with β-arrestin-1 (ARRB1) and with components of the IL6/JAK2/NF-κB/STAT3 pathway; disease-causing missense variants either abolish GTP binding/hydrolysis or produce gain-of-function changes in D2R signaling potency, and several variants specifically disrupt ciliary localization of Gαi1, collectively pointing to disrupted G protein nucleotide cycling, aberrant GPCR signal transduction, and cilia dysfunction as core pathogenic mechanisms."},"narrative":{"mechanistic_narrative":"GNAI1 encodes Gαi1, a heterotrimeric G protein α-subunit whose core activity is GTP binding and hydrolysis, a nucleotide cycle required for productive interaction with partners that recognize the GDP- or GTP-loaded states and for plasma membrane localization [PMID:34685729]. Gαi1 transduces inhibitory dopamine D2 receptor signaling, and disease-associated missense variants alter this transduction in opposite directions—producing gain-of-function increases in agonist potency and constitutive activity (T48K, T48I, C224Y, V332E) or loss of receptor responsiveness (G40C)—while nearly all variants impair GTP binding and hydrolysis [PMID:41329793]. Independently, GNAI1 is required for ciliogenesis: patient variants disrupt cilia assembly and function in C. elegans neurons and abolish ciliary localization of Gαi1 in human cells, defining cilia dysfunction as a distinct pathogenic axis [PMID:41052774, PMID:40894620]. Beyond canonical signaling, GNAI1 (with GNAI3) restrains the IL6/JAK2–STAT3 and NF-κB axes; combined loss activates these pathways through downstream GNAI2 [PMID:30836096], and GNAI1 acts as a suppressor of adenylate cyclase whose inhibition de-represses cAMP/PKA/CREB signaling [PMID:35678269]. GNAI1 physically associates with β-arrestin-1 (ARRB1) in a complex coupled to pro-survival ERK/JAK2-STAT3/mTOR signaling [PMID:42088441].","teleology":[{"year":2012,"claim":"Established GNAI1 as a functional suppressor of tumor cell motility and identified a post-transcriptional control mechanism, framing it as more than a passive signaling node.","evidence":"Gain- and loss-of-function with Transwell migration/invasion assays plus miR-320 mimic experiments in hepatocellular carcinoma cells","pmids":["23691483"],"confidence":"Medium","gaps":["Molecular mechanism linking GNAI1 to migration not defined","miR-320 targeting shown at protein level without 3'UTR reporter","Single cancer context"]},{"year":2019,"claim":"Placed GNAI1 (with GNAI3) as an upstream brake on inflammatory signaling, answering whether these subunits regulate JAK2/STAT3 and NF-κB and establishing a GNAI2-dependent downstream relay.","evidence":"Reciprocal Co-IP with IL6 pathway proteins plus genetic epistasis using double and conditional knockout mice with immunoblot, flow cytometry, and ELISA","pmids":["30836096"],"confidence":"High","gaps":["Direct GNAI1 substrate within the axis not defined","Functional redundancy with GNAI3 not fully resolved","Mechanism of pathway repression at molecular level unclear"]},{"year":2021,"claim":"Defined the biochemical consequence of pathogenic mutations by showing Gln52 substitutions abolish GTP binding/hydrolysis, mislocalize the protein, and break partner interactions—anchoring nucleotide cycling as the core function.","evidence":"GTP binding/hydrolysis assays, Co-IP with partners, and subcellular localization of mutant vs. wild-type Gαi1 in cell lines","pmids":["34685729"],"confidence":"Medium","gaps":["Single lab","Partner identities transducing the defect not fully enumerated","In vivo phenotype of mutants not tested"]},{"year":2022,"claim":"Demonstrated that GNAI1's inhibition of adenylate cyclase can be pharmacologically relieved, validating the cAMP/PKA/CREB axis as a druggable output of Gαi1 activity.","evidence":"DARTS-MS target identification, cAMP measurement, CREB phosphorylation, and PKA-inhibitor rescue in podocytes and diabetic mouse kidney","pmids":["35678269"],"confidence":"Medium","gaps":["Single lab","Binding site on GNAI1 not mapped","Selectivity of the small molecule for GNAI1 vs. other Gα not established"]},{"year":2025,"claim":"Resolved how syndrome variants alter receptor-coupled signaling by reconstituting D2R–Gαi1 coupling, revealing both gain- and loss-of-function variant classes and distinguishing them from their nucleotide-handling defects.","evidence":"Xenopus oocyte electrophysiology of D2R plus variant Gαi1, GTP-γ-S binding assays, and in silico modeling","pmids":["41329793"],"confidence":"High","gaps":["Mechanism of constitutive activity for individual variants not structurally defined","Receptor coupling tested only for D2R","Cellular consequences in patient-relevant cell types not assessed"]},{"year":2025,"claim":"Identified ciliogenesis as a distinct GNAI1 requirement, separating variants that disrupt cilia assembly/localization from those that do not and adding cilia dysfunction as a pathogenic axis independent of signaling potency.","evidence":"CRISPR-Cas9 knock-in of patient variants in C. elegans AWC neurons with morphology and chemotaxis assays, plus ciliary localization imaging in human ciliated cell lines","pmids":["41052774","40894620"],"confidence":"High","gaps":["Molecular mechanism of Gαi1 in cilia assembly not defined","Relationship between ciliary and D2R-signaling defects unresolved","Ciliary partners of Gαi1 not identified"]},{"year":2026,"claim":"Revealed a GNAI1-ARRB1 complex coupled to pro-survival signaling, showing that disrupting this physical interaction shifts cells toward autophagic death.","evidence":"DARTS, CETSA, and docking for direct binding plus Co-IP for GNAI1-ARRB1 complex disruption in NSCLC models","pmids":["42088441"],"confidence":"Medium","gaps":["Single lab","Direct vs. indirect nature of GNAI1-ARRB1 contact not structurally mapped","Mechanism connecting complex dissociation to autophagy not fully defined"]},{"year":null,"claim":"How GNAI1's distinct roles—nucleotide cycling at GPCRs, adenylate cyclase inhibition, ciliary function, and ARRB1/inflammatory pathway regulation—are integrated, and which are primary drivers of the GNAI1 syndrome phenotype, remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model linking variant class to specific phenotype","Tissue-specific contributions of each axis unknown","Direct molecular role of Gαi1 in cilia uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[0,1]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[1]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,6]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0]},{"term_id":"GO:0005929","term_label":"cilium","supporting_discovery_ids":[2]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,6]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[2]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3]}],"complexes":[],"partners":["ARRB1","GNAI3","NGB"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P63096","full_name":"Guanine nucleotide-binding protein G(i) subunit alpha-1","aliases":["Adenylate cyclase-inhibiting G alpha protein"],"length_aa":354,"mass_kda":40.4,"function":"Guanine nucleotide-binding proteins (G proteins) function as transducers downstream of G protein-coupled receptors (GPCRs) in numerous signaling cascades (PubMed:18434541, PubMed:33762731, PubMed:34239069, PubMed:35610220, PubMed:37935376, PubMed:37935377, PubMed:37963465, PubMed:38552625, PubMed:8774883, PubMed:38918398, PubMed:40080544). The alpha chain contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state (PubMed:18434541, PubMed:8774883). Signaling by an activated GPCR promotes GDP release and GTP binding (PubMed:18434541, PubMed:8774883). The alpha subunit has a low GTPase activity that converts bound GTP to GDP, thereby terminating the signal (PubMed:18434541, PubMed:8774883). Both GDP release and GTP hydrolysis are modulated by numerous regulatory proteins (PubMed:18434541, PubMed:8774883). Signaling is mediated via effector proteins, such as adenylate cyclase: inhibits adenylate cyclase activity of ADCY1, ADCY5 and ADCY6, leading to decreased intracellular cAMP levels (PubMed:8119955). The inactive GDP-bound form prevents the association of RGS14 with centrosomes and is required for the translocation of RGS14 from the cytoplasm to the plasma membrane. Required for normal cytokinesis during mitosis (PubMed:17635935). Required for cortical dynein-dynactin complex recruitment during metaphase (PubMed:22327364)","subcellular_location":"Nucleus; Cytoplasm; Cell membrane; Cytoplasm, cytoskeleton, microtubule organizing center, centrosome; Cytoplasm, cell cortex; Membrane","url":"https://www.uniprot.org/uniprotkb/P63096/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GNAI1","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GNAI1","total_profiled":1310},"omim":[{"mim_id":"621174","title":"CHOLESIN; CHLSN","url":"https://www.omim.org/entry/621174"},{"mim_id":"621173","title":"G PROTEIN-COUPLED RECEPTOR 146; GPR146","url":"https://www.omim.org/entry/621173"},{"mim_id":"619854","title":"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES; NEDHISB","url":"https://www.omim.org/entry/619854"},{"mim_id":"619344","title":"PURKINJE CELL PROTEIN 2; PCP2","url":"https://www.omim.org/entry/619344"},{"mim_id":"618558","title":"G PROTEIN SIGNALING MODULATOR 3; GPSM3","url":"https://www.omim.org/entry/618558"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Centrosome","reliability":"Supported"},{"location":"Principal piece","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Nucleoli","reliability":"Additional"},{"location":"Golgi apparatus","reliability":"Additional"},{"location":"Centriolar satellite","reliability":"Additional"},{"location":"Basal body","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":37.1}],"url":"https://www.proteinatlas.org/search/GNAI1"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P63096","domains":[{"cath_id":"3.40.50.300","chopping":"38-60_181-339","consensus_level":"medium","plddt":96.1262,"start":38,"end":339},{"cath_id":"1.10.400.10","chopping":"62-174","consensus_level":"medium","plddt":95.8395,"start":62,"end":174}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P63096","model_url":"https://alphafold.ebi.ac.uk/files/AF-P63096-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P63096-F1-predicted_aligned_error_v6.png","plddt_mean":93.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GNAI1","jax_strain_url":"https://www.jax.org/strain/search?query=GNAI1"},"sequence":{"accession":"P63096","fasta_url":"https://rest.uniprot.org/uniprotkb/P63096.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P63096/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P63096"}},"corpus_meta":[{"pmid":"30836096","id":"PMC_30836096","title":"GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2.","date":"2019","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/30836096","citation_count":80,"is_preprint":false},{"pmid":"23691483","id":"PMC_23691483","title":"GNAI1 Suppresses Tumor Cell Migration and Invasion and is Post-Transcriptionally Regulated by Mir-320a/c/d in Hepatocellular Carcinoma.","date":"2012","source":"Cancer biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23691483","citation_count":67,"is_preprint":false},{"pmid":"33473207","id":"PMC_33473207","title":"Variants in GNAI1 cause a syndrome associated with variable features including developmental delay, seizures, and hypotonia.","date":"2021","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33473207","citation_count":31,"is_preprint":false},{"pmid":"34685729","id":"PMC_34685729","title":"Pediatric Encephalopathy: Clinical, Biochemical and Cellular Insights into the Role of Gln52 of GNAO1 and GNAI1 for the Dominant Disease.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34685729","citation_count":27,"is_preprint":false},{"pmid":"35678269","id":"PMC_35678269","title":"Puerarin attenuates diabetic kidney injury through interaction with Guanidine nucleotide-binding protein Gi subunit alpha-1 (Gnai1) subunit.","date":"2022","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35678269","citation_count":24,"is_preprint":false},{"pmid":"39695099","id":"PMC_39695099","title":"Exosomal miR-320d promotes angiogenesis and colorectal cancer metastasis via targeting GNAI1 to affect the JAK2/STAT3 signaling pathway.","date":"2024","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/39695099","citation_count":22,"is_preprint":false},{"pmid":"37141638","id":"PMC_37141638","title":"Neuroglobin inhibits pancreatic cancer proliferation and metastasis by targeting the GNAI1/EGFR/AKT/ERK signaling axis.","date":"2023","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/37141638","citation_count":15,"is_preprint":false},{"pmid":"25573302","id":"PMC_25573302","title":"Variants in SELL, MRPS36P2, TP63, DDB2, CACNA1H, ADAM19, GNAI1, CDH13 and GABRG2 interact to confer risk of acne in Chinese population.","date":"2015","source":"The Journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/25573302","citation_count":10,"is_preprint":false},{"pmid":"26519098","id":"PMC_26519098","title":"Valproic acid mediates miR-124 to down-regulate a novel protein target, GNAI1.","date":"2015","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/26519098","citation_count":8,"is_preprint":false},{"pmid":"27534535","id":"PMC_27534535","title":"Integrated analysis of omics data using microRNA-target mRNA network and PPI network reveals regulation of Gnai1 function in the spinal cord of Ews/Ewsr1 KO mice.","date":"2016","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/27534535","citation_count":6,"is_preprint":false},{"pmid":"34819662","id":"PMC_34819662","title":"Novel de novo pathogenic variant in the GNAI1 gene as a cause of severe disorders of intellectual development.","date":"2021","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34819662","citation_count":5,"is_preprint":false},{"pmid":"35434560","id":"PMC_35434560","title":"A Foxo1-Klf2-S1pr1-Gnai1-Rac1 signaling axis is a critical mediator of Ostm1 regulatory network in T lymphopoiesis.","date":"2022","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/35434560","citation_count":2,"is_preprint":false},{"pmid":"40530109","id":"PMC_40530109","title":"Identification and functional analysis of GNAI1 as a biomarker associated with immune-related genes in pediatric acute myeloid leukemia.","date":"2025","source":"Translational cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/40530109","citation_count":2,"is_preprint":false},{"pmid":"41052774","id":"PMC_41052774","title":"Functional classification of GNAI1 disorder variants in Caenorhabditis elegans uncovers conserved and cell-specific mechanisms of dysfunction.","date":"2025","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/41052774","citation_count":1,"is_preprint":false},{"pmid":"40394057","id":"PMC_40394057","title":"miRNA-200a suppresses GNAI1 and PLCB4 to modulate skin pigmentation in cashmere goats.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40394057","citation_count":1,"is_preprint":false},{"pmid":"41022165","id":"PMC_41022165","title":"SOGA1 drives ovarian cancer progression via regulation of GNAI1 and activation of the TNF/NF-κB pathway.","date":"2025","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/41022165","citation_count":0,"is_preprint":false},{"pmid":"42088441","id":"PMC_42088441","title":"Patchouli alcohol triggers autophagic cell death in non-small cell lung cancer cells through targeting GNAI1 to dissociate the GNAI1/ARRB1 complex.","date":"2026","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/42088441","citation_count":0,"is_preprint":false},{"pmid":"41329793","id":"PMC_41329793","title":"GNAI1 missense mutations associated with a neurodevelopmental syndrome modify Gαi1 function.","date":"2025","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/41329793","citation_count":0,"is_preprint":false},{"pmid":"40894620","id":"PMC_40894620","title":"Functional classification of GNAI1 disorder variants in C. elegans uncovers conserved and cell-specific mechanisms of dysfunction.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40894620","citation_count":0,"is_preprint":false},{"pmid":"40873676","id":"PMC_40873676","title":"Dysregulation of G protein subunits in autism: decreased GNAO1 and elevated GNAI1 levels in ASD.","date":"2025","source":"Frontiers in psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/40873676","citation_count":0,"is_preprint":false},{"pmid":"41235373","id":"PMC_41235373","title":"A GNAI1 Pathogenic Variant Mimicking Cerebral Palsy: Expanding the Phenotypic Spectrum of GNAI1-Associated Neurodevelopmental Disorder.","date":"2025","source":"Clinical case reports","url":"https://pubmed.ncbi.nlm.nih.gov/41235373","citation_count":0,"is_preprint":false},{"pmid":"41797647","id":"PMC_41797647","title":"The protective role of FLI-1 in cardiac hypertrophy: Modulation of the IGF-1R/GNAI1/PLCG1 pathway.","date":"2026","source":"Histology and histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/41797647","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.08.18.670960","title":"Functional classification of  <i>GNAI1</i>  disorder variants in  <i>C. elegans</i>  uncovers conserved and cell-specific mechanisms of dysfunction","date":"2025-08-22","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.18.670960","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14360,"output_tokens":3185,"usd":0.045428,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10670,"output_tokens":2937,"usd":0.063387,"stage2_stop_reason":"end_turn"},"total_usd":0.108815,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2021,\n      \"finding\": \"Pathogenic mutations at Gln52 of GNAI1 (e.g., Gαi1[Gln52Pro]) abolish GTP binding and hydrolysis (the fundamental biochemical activity of Gαi1), cause defective interaction with partner proteins that recognize either GDP-loaded or GTP-loaded forms, and strongly reduce plasma membrane localization of the mutant proteins.\",\n      \"method\": \"Biochemical GTP binding/hydrolysis assays, co-immunoprecipitation with partner proteins, subcellular localization analysis of mutant vs. wild-type Gαi1 in cell lines\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal biochemical and cell-biological methods in a single study; single lab\",\n      \"pmids\": [\"34685729\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Five GNAI1 syndrome-associated missense variants alter D2 receptor (D2R) signaling in Xenopus oocytes: four variants (T48K, T48I, C224Y, V332E) cause gain-of-function increases in dopamine potency and constitutive G protein activity, while G40C is unresponsive to D2R activation. All variants show reduced GTP-γ-S binding rates and undetectable GTP hydrolysis except T48I, which shows accelerated binding and hydrolysis.\",\n      \"method\": \"Xenopus laevis oocyte electrophysiology expressing D2R plus variant Gαi1 proteins; GTP-γ-S binding assays; in silico modeling\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted receptor-G protein signaling in oocytes with biochemical GTP assays; multiple variants tested with orthogonal methods in one rigorous study\",\n      \"pmids\": [\"41329793\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GNAI1 is required for ciliogenesis in human ciliated cells. Patient-variant orthologues T48I, K272R, A328P, and V334E disrupt both cilia assembly and function in C. elegans AWC neurons; D173V/K270R/A326P human GNAI1 variants disrupt ciliary localization of Gαi1 in human ciliated cell lines; M88V and I321T variants have no detectable effect on cilia phenotypes.\",\n      \"method\": \"CRISPR-Cas9 knock-in of patient variants in C. elegans; cilia morphology assays; chemotaxis behavioral assays; human ciliated cell lines with variant Gαi1 expression and ciliary localization imaging\",\n      \"journal\": \"Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — CRISPR-edited whole-organism model with multiple orthogonal readouts (morphology, behavior, localization), validated in human cells, published and preprint concordant\",\n      \"pmids\": [\"41052774\", \"40894620\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GNAI1 and GNAI3 interact with proteins in the IL6 signaling pathway (shown by immunoprecipitation) and their combined loss activates the JAK2-TRAF6-TAK1-CHUK/IKKβ axis (NF-κB) and JAK2-STAT3 axis, leading to upregulation of GNAI2, GP130, and iNOS and expansion of MDSCs; conditional Gnai2 deletion in CD11c+ cells of GNAI1/3 double-knockout mice prevents NF-κB and STAT3 activation, placing GNAI2 downstream of GNAI1/3 in this pathway.\",\n      \"method\": \"Immunoprecipitation of GNAI1/3 with IL6 pathway proteins from colon tumor tissue and MEFs; genetic epistasis using conditional Gnai2 knockout in DKO mice; immunoblot; flow cytometry; ELISA\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP plus genetic epistasis (double and conditional KO) plus multiple orthogonal readouts; replicated across cell types and in vivo\",\n      \"pmids\": [\"30836096\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"GNAI1 suppresses migration and invasion of hepatocellular carcinoma cells; knockdown of GNAI1 increases migration/invasion and overexpression reduces it. miR-320a/c/d target GNAI1 at the post-transcriptional level (protein downregulated without mRNA change in HCC), and miR-320 mimics reduce GNAI1 protein and promote cell migration/invasion.\",\n      \"method\": \"Lentiviral GNAI1 overexpression; siRNA knockdown; Transwell migration/invasion assays; Western blot after miR-320a/c/d mimic transfection; qRT-PCR\",\n      \"journal\": \"Cancer biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — loss- and gain-of-function with defined phenotypic readout; miRNA-target relationship confirmed by protein-level measurement; single lab\",\n      \"pmids\": [\"23691483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Valproic acid induces miR-124, which targets GNAI1 mRNA to reduce GNAI1 protein levels, thereby de-repressing adenylate cyclase, increasing cAMP, and elevating BDNF expression; miR-124 mimic or inhibitor can correspondingly manipulate GNAI1 protein and BDNF mRNA levels.\",\n      \"method\": \"miR-124 mimic/inhibitor transfection; Western blot for GNAI1; qRT-PCR for Bdnf mRNA; in silico miRNA target prediction validated by protein-level changes\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab; miRNA-target relationship inferred from expression changes without 3'UTR reporter assay; no direct cAMP measurement confirmed\",\n      \"pmids\": [\"26519098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Puerarin directly binds GNAI1 (identified by DARTS combined with mass spectrometry), and this interaction inhibits GNAI1's suppression of adenylate cyclase, increasing cAMP production and activating PKA/CREB signaling in podocytes; PKA inhibition abrogates puerarin's protective effects on high-glucose-induced apoptosis.\",\n      \"method\": \"Drug affinity responsive target stability (DARTS) assay plus mass spectrometry for target ID; cAMP measurement in human podocytes and diabetic mouse kidney; CREB phosphorylation by Western blot; Rp-cAMP PKA inhibition rescue experiment\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding identified by DARTS-MS, functional consequence validated by cAMP measurement and pharmacological epistasis; single lab\",\n      \"pmids\": [\"35678269\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Neuroglobin (NGB) physically interacts with GNAI1 (shown by co-IP) and reduces GNAI1 protein expression; this interaction inhibits downstream EGFR phosphorylation and the AKT/ERK pathway, suppressing pancreatic cancer proliferation and metastasis.\",\n      \"method\": \"Co-immunoprecipitation; Western blot for GNAI1 and p-EGFR/AKT/ERK; in vitro and in vivo functional assays with NGB overexpression\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP; pathway placement inferred from correlated protein changes without direct epistasis; single lab\",\n      \"pmids\": [\"37141638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"miR-320d in colorectal cancer-derived exosomes is transferred to vascular endothelial cells where it targets GNAI1 3'UTR, reducing GNAI1 protein, which increases JAK2/STAT3 activation and VEGFA production, enhancing endothelial migration and angiogenesis.\",\n      \"method\": \"Exosome transfer experiments; luciferase reporter assay (implied by 'targeting' GNAI1); Western blot for GNAI1, JAK2/STAT3, VEGFA; endothelial migration and tube formation assays; in vivo tumor models\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab; mechanistic link between GNAI1 reduction and JAK2/STAT3 not directly established with rescue experiment; abstract does not confirm 3'UTR reporter\",\n      \"pmids\": [\"39695099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Patchouli alcohol (PA) directly binds GNAI1 (confirmed by DARTS, molecular docking, and CETSA), disrupts the GNAI1-ARRB1 (β-arrestin-1) protein complex, and this dissociation inhibits ERK/JAK2-STAT3/mTOR pro-survival signaling, triggering autophagic cell death in non-small cell lung cancer cells.\",\n      \"method\": \"DARTS, CETSA, and molecular docking for direct target ID; co-immunoprecipitation for GNAI1-ARRB1 interaction; Western blot for downstream pathway proteins; in vitro and in vivo NSCLC models\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — three orthogonal methods for direct binding, plus Co-IP for interaction disruption; single lab\",\n      \"pmids\": [\"42088441\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Transcriptome analysis of Ostm1-null mouse DN1 T cells identified a Foxo1-Klf2-S1pr1-Gnai1-Rac1 signaling axis downstream of Ostm1; Ostm1 ablation disrupts this axis and impairs early T cell development, and transgenic Ostm1 rescue in DN1 cells normalizes the pathway and T cell subpopulations.\",\n      \"method\": \"Transcriptome analysis of sorted DN1 cells from Ostm1 KO mice; genetic rescue with transgenic Ostm1 expression; flow cytometry for T cell subpopulations\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — Gnai1 pathway placement is from transcriptome correlation in KO context; no direct manipulation of Gnai1 in this study\",\n      \"pmids\": [\"35434560\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GNAI1 encodes Gαi1, a heterotrimeric G protein α-subunit that inhibits adenylate cyclase (suppressing cAMP/PKA/CREB signaling), transduces inhibitory GPCR signals (including dopamine D2R), is required for ciliogenesis, physically interacts with β-arrestin-1 (ARRB1) and with components of the IL6/JAK2/NF-κB/STAT3 pathway; disease-causing missense variants either abolish GTP binding/hydrolysis or produce gain-of-function changes in D2R signaling potency, and several variants specifically disrupt ciliary localization of Gαi1, collectively pointing to disrupted G protein nucleotide cycling, aberrant GPCR signal transduction, and cilia dysfunction as core pathogenic mechanisms.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GNAI1 encodes Gαi1, a heterotrimeric G protein α-subunit whose core activity is GTP binding and hydrolysis, a nucleotide cycle required for productive interaction with partners that recognize the GDP- or GTP-loaded states and for plasma membrane localization [#0]. Gαi1 transduces inhibitory dopamine D2 receptor signaling, and disease-associated missense variants alter this transduction in opposite directions—producing gain-of-function increases in agonist potency and constitutive activity (T48K, T48I, C224Y, V332E) or loss of receptor responsiveness (G40C)—while nearly all variants impair GTP binding and hydrolysis [#1]. Independently, GNAI1 is required for ciliogenesis: patient variants disrupt cilia assembly and function in C. elegans neurons and abolish ciliary localization of Gαi1 in human cells, defining cilia dysfunction as a distinct pathogenic axis [#2]. Beyond canonical signaling, GNAI1 (with GNAI3) restrains the IL6/JAK2–STAT3 and NF-κB axes; combined loss activates these pathways through downstream GNAI2 [#3], and GNAI1 acts as a suppressor of adenylate cyclase whose inhibition de-represses cAMP/PKA/CREB signaling [#6]. GNAI1 physically associates with β-arrestin-1 (ARRB1) in a complex coupled to pro-survival ERK/JAK2-STAT3/mTOR signaling [#9].\",\n  \"teleology\": [\n    {\n      \"year\": 2012,\n      \"claim\": \"Established GNAI1 as a functional suppressor of tumor cell motility and identified a post-transcriptional control mechanism, framing it as more than a passive signaling node.\",\n      \"evidence\": \"Gain- and loss-of-function with Transwell migration/invasion assays plus miR-320 mimic experiments in hepatocellular carcinoma cells\",\n      \"pmids\": [\"23691483\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism linking GNAI1 to migration not defined\", \"miR-320 targeting shown at protein level without 3'UTR reporter\", \"Single cancer context\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Placed GNAI1 (with GNAI3) as an upstream brake on inflammatory signaling, answering whether these subunits regulate JAK2/STAT3 and NF-κB and establishing a GNAI2-dependent downstream relay.\",\n      \"evidence\": \"Reciprocal Co-IP with IL6 pathway proteins plus genetic epistasis using double and conditional knockout mice with immunoblot, flow cytometry, and ELISA\",\n      \"pmids\": [\"30836096\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct GNAI1 substrate within the axis not defined\", \"Functional redundancy with GNAI3 not fully resolved\", \"Mechanism of pathway repression at molecular level unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined the biochemical consequence of pathogenic mutations by showing Gln52 substitutions abolish GTP binding/hydrolysis, mislocalize the protein, and break partner interactions—anchoring nucleotide cycling as the core function.\",\n      \"evidence\": \"GTP binding/hydrolysis assays, Co-IP with partners, and subcellular localization of mutant vs. wild-type Gαi1 in cell lines\",\n      \"pmids\": [\"34685729\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Partner identities transducing the defect not fully enumerated\", \"In vivo phenotype of mutants not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrated that GNAI1's inhibition of adenylate cyclase can be pharmacologically relieved, validating the cAMP/PKA/CREB axis as a druggable output of Gαi1 activity.\",\n      \"evidence\": \"DARTS-MS target identification, cAMP measurement, CREB phosphorylation, and PKA-inhibitor rescue in podocytes and diabetic mouse kidney\",\n      \"pmids\": [\"35678269\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Binding site on GNAI1 not mapped\", \"Selectivity of the small molecule for GNAI1 vs. other Gα not established\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Resolved how syndrome variants alter receptor-coupled signaling by reconstituting D2R–Gαi1 coupling, revealing both gain- and loss-of-function variant classes and distinguishing them from their nucleotide-handling defects.\",\n      \"evidence\": \"Xenopus oocyte electrophysiology of D2R plus variant Gαi1, GTP-γ-S binding assays, and in silico modeling\",\n      \"pmids\": [\"41329793\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of constitutive activity for individual variants not structurally defined\", \"Receptor coupling tested only for D2R\", \"Cellular consequences in patient-relevant cell types not assessed\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identified ciliogenesis as a distinct GNAI1 requirement, separating variants that disrupt cilia assembly/localization from those that do not and adding cilia dysfunction as a pathogenic axis independent of signaling potency.\",\n      \"evidence\": \"CRISPR-Cas9 knock-in of patient variants in C. elegans AWC neurons with morphology and chemotaxis assays, plus ciliary localization imaging in human ciliated cell lines\",\n      \"pmids\": [\"41052774\", \"40894620\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of Gαi1 in cilia assembly not defined\", \"Relationship between ciliary and D2R-signaling defects unresolved\", \"Ciliary partners of Gαi1 not identified\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Revealed a GNAI1-ARRB1 complex coupled to pro-survival signaling, showing that disrupting this physical interaction shifts cells toward autophagic death.\",\n      \"evidence\": \"DARTS, CETSA, and docking for direct binding plus Co-IP for GNAI1-ARRB1 complex disruption in NSCLC models\",\n      \"pmids\": [\"42088441\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Direct vs. indirect nature of GNAI1-ARRB1 contact not structurally mapped\", \"Mechanism connecting complex dissociation to autophagy not fully defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How GNAI1's distinct roles—nucleotide cycling at GPCRs, adenylate cyclase inhibition, ciliary function, and ARRB1/inflammatory pathway regulation—are integrated, and which are primary drivers of the GNAI1 syndrome phenotype, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model linking variant class to specific phenotype\", \"Tissue-specific contributions of each axis unknown\", \"Direct molecular role of Gαi1 in cilia uncharacterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005929\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 6]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ARRB1\", \"GNAI3\", \"NGB\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}